StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Seloken / Toprol-XL (metoprolol) by Quarter

Seloken / Toprol-XL (metoprolol) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Seloken / Toprol-XL (metoprolol): $157M in Q2 2026, up 6.1% from a year earlier.

Latest, Q2 2026
157
Period ended Jun 30, 2026
Change on a year earlier
+6.1%
148 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Seloken | 157 | | 6 | | 2 | | - | | - | | 153 | | 6 | | 2 | | 3 | | ( 1 ) | | ( 3 ) | | 1 | | 12 | | 4”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSeloken / Toprol-XL (metoprolol) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026157+6.1%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026180+11.8%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025139-0.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025160+6.7%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025148-1.3%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025161-2.4%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024140-2.8%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024150-2.0%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024150-8.5%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024165-7.8%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023144-8.3%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023153-35.7%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023164-26.5%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023179-26.6%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022157-22.3%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022238+1.7%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up seloken / Toprol-XL (metoprolol)

Cite this data

StockData. (2026). AstraZeneca Seloken / Toprol-XL (metoprolol) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-seloken-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.